ApiJect

Stamford, United States Founded: 2015 • Age: 11 yrs
Medicine injectors are manufactured by ApiJect for medical applications.

About ApiJect

ApiJect is a Healthcare company based in Stamford (United States) founded in 2015 by Marc Koska and Jay Walker. Medicine injectors are manufactured by ApiJect for medical applications. ApiJect has raised $111 million across 2 funding rounds from investors including Royalty Pharma, Jefferies and DFC. Its chief executive, as recorded, is Jay Walker. ApiJect offers products and services including Blow-Fill-Seal Container, Apiject Platform, and Prefilled Injector. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is Apiject Systems, Corp. Its competitors include Exela Pharma, August Bioservices and INCOG BioPharma Services; 3 of its 3 listed competitors have raised funding.

Company details

ApiJect manufacturer of medicine injectors, focusing on providing healthcare solutions, biopharma outsourcing, cdmo, small molecules peptides, formulation, and injectibles. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Stamford, United States
  • Founders Marc Koska, Jay Walker
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website apiject.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Apiject Systems, Corp.
Key Metrics
  • Total Equity Funding
    $111M (USD)

    in 2 rounds

  • Latest Funding Round
    $111M (USD), Series D

    Apr 2022

  • Investors

Products & Services of ApiJect

ApiJect offers a comprehensive portfolio of products and services, including Blow-Fill-Seal Container, Apiject Platform, and Prefilled Injector.

Blow-Fill-Seal Container
Medical Device

Aseptic container for prefilled injections ensuring safety and sterility.

Apiject Platform
Drug Delivery Platform

Platform simplifying injections for pharmaceuticals and global health use.

Prefilled Injector
Injection Technology

Device enabling easy administration by non-professionals in various settings.

Apps and channels of ApiJect

its YouTube channel ApiJect Systems, Corp. has 2.62K subscribers and 30 videos.

ApiJect Systems, Corp.
YouTube 2.62K subscribers 30 videos Science & Technology
Open channel

Videos from ApiJect

The most watched videos on ApiJect's YouTube channel, ApiJect Systems, Corp. (2.62K subscribers). Click a video to play it here.

The ApiJect Platform: Transforming Drug Delivery - Short
248.8K views
4 - Introduction to Blow-Fill-Seal / Types of Blow-Fill-Seal Machines
1.3K views
The ApiJect Platform: Transforming Drug Delivery - Extended
763 views
28 - Introduction to Blow-Fill-Seal / Blow-Fill-Seal Machine and Support Systems
651 views

More on ApiJect Systems, Corp..

Funding Insights of ApiJect

ApiJect has successfully raised a total of $111M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $111 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $111M
  • Total Rounds 2
  • Last Round Series D β€” $111M
  • First Round $590M

    (Nov 2020)

  • Investors Count 3

All 2 funding rounds of ApiJect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2022$111MSeries D–Royalty Pharma, Jefferies
–
Nov 2020$590MDebt – Conventional––
Valuation history

3 investors in total: 3 institutional.

Investors in ApiJect

ApiJect has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Royalty Pharma, Jefferies and DFC.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made in marketed and late-stage biopharmaceutical companies.
1996royaltypharma.comNew York, United States
Government agency supporting the development of SMEs
2019dfc.gov
Merger and acquisitions advisory services are provided across multiple sectors.
1962jefferies.comNew York, United States
Premium access

Investor details for ApiJect

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ApiJect

34 people are tracked at ApiJect (22 in leadership, 12 in team).

NameRoleGroup
Marc Koska
Co-Founder & Head of ProductLeadership
Jay Walker
Co-Founder & CEOLeadership
Peter Stone
EVP & Global Head of M&ALeadership
Ed Kelley
Chief Global Health OfficerLeadership
Bo Kowalczyk
Chief Commercial Officer, ApiJectLeadership
Michael Buzecky
Senior Director Process Development & PackagingLeadership
Philip Tull
Vp, Government Projects And Government ContractsLeadership
Josh Myers
Vp, Distributed Manufacturing & Supply ChainLeadership
Kelly Wong Mba
Project DirectorLeadership
Christian Eichhorn Pe
Vice President, Process Development And PackagingLeadership
Paul Rutter
Senior Vice President Clinical AffairsLeadership
Lauren Greenberg
Vice President, Device DevelopmentLeadership
Stephanie Summe
Senior Director Device DevelopmentLeadership
Molly Weaver
Chief Technology OfficerLeadership
Magdalena Fincham
Head Of Intellectual PropertyLeadership
Jon Burgess
General Manager, OrlandoLeadership
Evan Walker
Vice President MarketingLeadership
Emily Schimek
Sr. Director, Device DevelopmentLeadership
Jon Ellenthal
PresidentLeadership
Laura Weidner
Head Of Corporate Development And QualityLeadership

14 more people are available in the full profile.

Premium access

Complete people profiles for ApiJect

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ApiJect

3 dated milestones of ApiJect across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded ApiJect is founded.
  2. Funding First funding round of $590.0M.
  3. Funding Latest funding round, Series D, of $111.0M.

Competitors of ApiJect

ApiJect has 3 listed competitors in our database, 3 of them funded. They include Exela Pharma, August Bioservices and INCOG BioPharma Services.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
exelapharma.com2005Lenoir, United States$7.09M247
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
augustbio.com2017Nashville, United States$88.6M86
Diversified research services for clinical solutions are offered.
incogbiopharma.com2020United States$86.63M
Injectable drug products are manufactured by this biopharma CDMO.
Premium access

Detailed competitors of ApiJect

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ApiJect

The website of ApiJect (apiject.com) receives about 2.2K visits a month.

  • Monthly visits
    2.2K

    ▼ 61.5% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as ApiJect (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Apiject

Premium access

Complete news archive for ApiJect

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ApiJect

ApiJect was founded in 2015 and raised its 1st funding round 5 years after it was founded.

ApiJect is headquartered in Stamford, United States. It is registered at Stamford, Connecticut, United States.

Jay Walker is the CEO of ApiJect, as recorded in our data. They have also founded this company.

ApiJect is a funded company, having raised a total of $111M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $590M, raised on Nov 2020.

ApiJect manufacturer of medicine injectors, focusing on providing healthcare solutions, biopharma outsourcing, cdmo, small molecules peptides, formulation, and injectibles. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

ApiJect's top competitors include Exela Pharma, August Bioservices and INCOG BioPharma Services.

ApiJect offers Blow-Fill-Seal Container, Apiject Platform, and Prefilled Injector.

ApiJect has 3 investors. Key investors include Royalty Pharma, Jefferies, and DFC.

ApiJect operates through Apiject Systems, Corp..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available